An Extension Study to Investigate the Safety and Durability of Clinical Activity of CAL-101 in Patients with Hematologic Malignancies

ID Number 13-1123

Principal Investigator(s)
Joshua Brody

Department(s) or Division(s)
Hematology and Medical Oncology


The purpose of this study is to see if an experimental drug named GS-1101, also known as CAL-101,  is safe to give to people with your type of cancer and to see how long it affects you and your cancer.  “Experimental” means that this study drug is being tested in people and has not been approved by the United States Food and Drug Administration (FDA).

Contact Information

(212) 824-7309

Recruiting Patients: No